Skip to main content
Skip to content

Duplicate Document

This document appears to be a copy. The original version is:

EFTA Document EFTA01493409
Case File
efta-efta01493409DOJ Data Set 10Correspondence

EFTA Document EFTA01493409

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01493409
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
FINANCIAL TRUST COMPANY INC ACCT. For the Period 9/1/12 to 9/30/12 Note P indicates position adjusted for Pending Trade Activity. Unrealized GainiLoss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional information. Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc Pike Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 24.21 16,535.000 400,312.35 251,475.52 148,836.83 04033A-10-0 ARIA BIOGEN IDEC INC 09062X-10-3 BIIB FACEBOOK INC-A 30303M-10-2 FB 149.21 2,095.000 312.594.95 250,454.95 62,140.00 21.66 17.500 003 379.050.00 665,000 00 (285,950.00) Total US Large Cap Equity US Small Cap Equity P PENNANTPARK INVESTMENT CORP 708062-10-4 PNNT 10 61 $1,091,967.30 81,166,930.47 (574.973.17) 30.00 0.00% 0.00 10 56 % US Small/Mid Cap Equity P CASELLA WASTE SYSTEMS INC 4.27 0.00 CL A 147448-10-4 CWST JP Morgan Account Page 5 of 36 Consolidated Statement Page 9 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-000 16266 SDNY_GM_00285464 EFTA01493409

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.